Find Grants

Search results

• Prot # CL0018-01: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

  Hoel, A. W.

  Lutonix, Inc.

  4/9/14 → 4/9/25

  Project: Research project

• Prot#718-CIH-201: A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants with Huntington's Disease

  Bega, D.

  Parexel, Sage Therapeutics, Inc.

  4/11/22 → 4/11/25

  Project: Research project

• Prot#EX9536-4773: Effect of Semaglutide 2.4 mg once-weekly on function and symptoms in subjects with obesity-related heart failure with preserved ejection fraction, and type 2 diabetes

  Patel, R. B.

  Novo Nordisk Inc.

  4/11/22 → 4/11/25

  Project: Research project

• Exploring Patient Experiences and Characteristics of Women with Endometriosis and Migraine

  Bailey, S. C.

  Lundbeck Inc.

  4/12/22 → 4/12/25

  Project: Research project

• Protocol: IPH4102-201: TELLOMAK: An open label, multi-cohort, multi-center phase II study evaluating the efficacy and safety of IPH4102 alone or in combination with chemotherapy in patients with Advanced T-cell lymphoma

  Zhou, A.

  Medpace Clinical Research LLC, Innate Pharma SA

  4/12/22 → 4/12/25

  Project: Research project

• Robotic Architected Materials with Distributed Sensorimotor Capabilities via Free-form Electrochemical Composites

  Truby, R. L.

  Air Force Office of Scientific Research

  4/15/22 → 4/14/25

  Project: Research project

• Prot#CP2018-1: ICE AFIB IDE Study: AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment during Concomitant On-Pump Endo

  McCarthy, P. M.

  AtriCure, Inc.

  4/17/19 → 4/17/25

  Project: Research project

• ATTRIBUTE_CM Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects with Symptomatic Transthyretin Amyloid Cardiomyopathy. Prot#AG10-301

  Shah, S. J.

  PRA Health Sciences, Eidos Therapeutics, Inc.

  4/18/19 → 4/18/25

  Project: Research project

• Prot #MK-3475-676: A Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette- Guerin (BCG) in Participants with High-risk Non-muscle Invasive Bladder Cance

  Meeks, J. J.

  Merck Sharp & Dohme Corporation

  4/18/22 → 4/18/25

  Project: Research project

• Prot#R668-AD-2024: Neuropsychologic Assessment of Dupilumab-Treated Adolescents with Moderate-to-Severe Atopic Dermatitis

  Paller, A.

  ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

  4/19/22 → 4/19/25

  Project: Research project

• Observational Data Collection for Autoregulation Algorithm Development

  Hogue, C. W.

  Edwards Lifesciences LLC

  4/20/22 → 4/20/25

  Project: Research project

• Prot #WD001: Safety of a Real-time Continuous Glucose Monitor-based Insulin Bolus Calculator: The “CGM-IBC” Study

  Aleppo, G.

  WellDoc, Inc.

  4/21/22 → 4/21/25

  Project: Research project

• Prot #ISA101b-HN-01-17: A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study of Cemiplimab Versus the Combination of Cemiplimab With ISA101b in the Treatment of Subjects With HPV16-Positive Platin-Resistant Oropharyngeal Cancer (OPC)

  Chae, Y. K.

  Syneos Health, Inc., ISA Therapeutics B.V.

  4/22/19 → 4/22/25

  Project: Research project

• Prot #FOR46-001: A Phase 1 Study of FOR46 Administered Every 21 Days in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  VanderWeele, D. J.

  ICON Clinical Research, LLC, Fortis Therapeutics, Inc.

  4/26/19 → 4/26/25

  Project: Research project

• Prot#RIV-HU6-2201: NUECL for Exploratory Phase 2A, Double-Blind, Placebo-Controlled Dose Escalation Study to Determine the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of HU6 in Subjects with Obese Heart Failure with Preserved Ejection Fra

  Shah, S. J.

  Rivus Pharmaceuticals, Inc.

  4/26/22 → 4/26/25

  Project: Research project

• Prot #ADCT-901-101: A Phase 1, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 as Monotherapy in Patients With Selected Advanced Solid Tumors

  Mahalingam, D.

  Clinipace, Inc., ADC Therapeutics Sarl

  4/27/22 → 4/27/25

  Project: Research project

• Prot #RIN-PF-301: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

  Dematte D'Amico, J. E.

  United Therapeutics Corporation

  4/28/22 → 4/28/25

  Project: Research project

• Prot #CM4620-203: A Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study of Auxora in Patients with Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome (CARPO)

  Keswani, R. N.

  Emas Pharma Limited, CalciMedica, Inc.

  4/28/22 → 4/28/25

  Project: Research project

• From Percolation to Passivation (P2P): Multiscale Prediction and Interrogation of Surface and Oxidation Phenomena in Multi-Principal Element Alloys (MPEAs)

  Rondinelli, J. M.

  Johns Hopkins University, Office of Naval Research

  5/1/20 → 4/30/25

  Project: Research project

• Multidisciplinary Visual Sciences Training Program

  DeVries, S. H.

  NATIONAL EYE INSTITUTE

  5/1/20 → 4/30/25

  Project: Research project

• Center for Smart Use of Technology to Assess Real-world Outcomes (C-STAR)

  Lieber, R. L.

  Shirley Ryan AbilityLab, National Institute of Child Health & Human Development (NICHD)

  5/1/20 → 4/30/25

  Project: Research project

• Beach & Rusie 2021 Supplement

  Janulis, P. F., Beach, L. B. & D'Aquila, R. T.

  National Institute of Allergy and Infectious Diseases

  4/1/20 → 4/30/25

  Project: Research project

• Laiteerapong 2021 Supplement

  D'Aquila, R. T.

  National Institute of Allergy and Infectious Diseases

  4/1/20 → 4/30/25

  Project: Research project

• Lorenzo 2021 Supplement

  Lorenzo Redondo, R.

  National Institute of Allergy and Infectious Diseases

  4/1/20 → 4/30/25

  Project: Research project

• Pyra 2021 Supplement

  D'Aquila, R. T.

  National Institute of Allergy and Infectious Diseases

  4/1/20 → 4/30/25

  Project: Research project